SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mangalam Drugs & Organics informs about certificate

25 Apr 2024 Evaluate

In terms of Regulation 40(9) / 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time Mangalam Drugs & Organics has informed that it attached the Certificate for the period from 01st April 2023 to 31st March, 2024 issued by Mustafa Bohra & Associates- Practicing Company Secretaries.

The above information is a part of company’s filings submitted to BSE.

Mangalam Drugs&Org. Share Price

30.69 0.00 (0.00%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1839.85
Dr. Reddys Lab 1293.00
Cipla 1340.75
Zydus Lifesciences 940.00
Lupin 2344.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×